Tag: bullish forecast
No posts to display
Top News
Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in...
Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.
- Our Sponsors Ad -